Bruker Daltonics Announces Opening of maXis™ U.S. Demonstration Facility
News Mar 06, 2009
Bruker Daltonics has announced the opening of its Massachusetts demonstration facility for the ultra-high resolution time-of-flight (UHR-TOF) maXis™ mass spectrometer, as well as several maXis installations in top-tier U.S. life-science research laboratories.
The maXis, which Bruker will exhibit at PITTCON 2009 next week in Chicago, is said to be the only high-performance mass spectrometer available that simultaneously fulfills the two previously incompatible requirements in modern mass spectrometry of ultra-high mass resolution and fast UHPLC separations.
maXis is designed to deliver the combination of exceptional mass accuracy of better than 1 ppm, ultra-high mass resolving power of 40,000 to 60,000, dynamic range over 5 orders of magnitude, high m/z capabilities, stability allowing 1.5 mDa high-resolution extracted ion chromatograms (hrEIC), as well as outstanding sensitivity, all in MS and MS/MS mode and all maintained simultaneously even when coupled to separations fast liquid chromatography systems.
Bruker Daltonics claims that maXis is already well proven as an exceptional tool in quantitative proteomics, peptide and intact protein analysis in addition to small molecule identification using the unique SmartFormula™ 3D method for on-the-fly unambiguous molecular formula read-out, as co-developed with Pfizer, UK.
Professor Richard Caprioli of the Vanderbilt University School of Medicine plans to use the maXis in his research on changes in protein expression in various disease states.
Prof. Caprioli commented: “The performance of the maXis in our laboratory after the installation has shown that we will be able to achieve new levels of confidence in protein identification, and quantification of changes in protein expressions levels, as well as those for drugs and metabolites. We see this instrument as highly complementary to our extensive research program in profiling changes in protein expression levels using MALDI-TOF imaging.”
At PITTCON 2009, Professor Jonathan V. Sweedler from the University of Illinois at Urbana will present maXis data demonstrating the ability to characterize neuropeptides in samples as small as a single neuron with an unprecedented combination of very high resolution, high sensitivity and tandem MS capabilities.
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
Comments | 0 ADD COMMENT
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018